| 000 | 01678 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517093049.0 | ||
| 264 | 0 | _c20180116 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a2160-7648 | ||
| 024 | 7 |
_a10.1002/cpdd.110 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOlsson, Håkan | |
| 245 | 0 | 0 |
_aPharmacokinetics and bioavailability of a new testosterone gel formulation in comparison to Testogel® in healthy men. _h[electronic resource] |
| 260 |
_bClinical pharmacology in drug development _c09 2014 |
||
| 300 |
_a358-64 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aGels |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 | _aHormone Replacement Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSkin Absorption |
| 650 | 0 | 4 |
_aTestosterone _xadministration & dosage |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSandström, Rikard | |
| 700 | 1 | _aNeijber, Anders | |
| 700 | 1 | _aCarrara, Dario | |
| 700 | 1 | _aGrundemar, Lars | |
| 773 | 0 |
_tClinical pharmacology in drug development _gvol. 3 _gno. 5 _gp. 358-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cpdd.110 _zAvailable from publisher's website |
| 999 |
_c25972397 _d25972397 |
||